Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia2Department of Medicine, Emory University, Atlanta, Georgia3Division of Cardiology, Department of Medicine, Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia2Department of Medicine, Emory University, Atlanta, Georgia.
JAMA Cardiol. 2016 Oct 1;1(7):779-786. doi: 10.1001/jamacardio.2016.2173.
Electrocardiography (ECG) may detect subclinical cardiovascular disease (CVD) in asymptomatic individuals, but its role in assessing adverse events beyond traditional risk factors is not clear. Interval and vector data that are commonly available on modern ECGs may offer independent prognostic information that improves risk classification.
To derive and validate a CVD risk equation based on ECG metrics and to determine its incremental benefit in addition to the Framingham risk score (FRS).
DESIGN, SETTING, AND PARTICIPANTS: This study included 3640 randomly selected community-based adults aged 40 to 74 years without known CVD from the First National Health and Nutrition Examination Survey (NHANES I) cohort (1971-1975) and 6329 from the NHANES III cohort (1988-1994). Participants were sampled from across the United States. A risk score to assess incident nonfatal and fatal CVD events was derived based on computer-generated ECG data, including frontal P, R, and T axes; heart rate; and PR, QRS, and QT intervals from NHANES I. The most prognostic variables, along with age and sex, were incorporated into the NHANES ECG risk equation. The equation was evaluated in the NHANES III cohort for an independent validation. Follow-up in the NHANES III cohort was completed on December 31, 2006. Data for this study were analyzed from August 11, 2015, to May 20, 2016.
The primary end point was CVD death. Secondary outcomes included 10-year ischemic heart disease and all-cause death.
The final study sample included 9969 participants (4714 men [47.3%]; 5255 women [52.7%]; mean [SD] age, 55.3 [10.1] years) from both cohorts. Frontal T axis, heart rate, and heart rate-corrected QT interval were the most significant ECG factors in the NHANES I cohort. In the validation cohort (NHANES III), the equation provided for prognostic information for fatal CVD with a hazard ratio (HR) of 3.23 (95% CI, 2.82-3.72); the C statistic was 0.79 (95% CI, 0.76-0.81). When added to the FRS in Cox proportional hazards regression models, the categorical (1%, 5%, and 10% cutoffs) net reclassification improvement was 24%. When the FRS and ECG scores were combined in a single model, the C statistic improved by 0.04 (95% CI, 0.02-0.06) to 0.80 (95% CI, 0.77-0.82). Similar improvements were noted when the ECG score was added to the pooled cohort equation. When the equation for prognostic information about ischemic heart disease and all-cause death was evaluated, the results were similar.
An ECG risk score based on age, sex, heart rate, frontal T axis, and QT interval assesses the risk for CVD and compares favorably with the FRS alone in an independent cohort of asymptomatic individuals. Although the ECG risk equation is low cost, further research is needed to ascertain whether this additional step in risk stratification may improve prevention efforts and reduce CVD events.
心电图(ECG)可能会在无症状个体中检测到亚临床心血管疾病(CVD),但它在评估传统风险因素之外的不良事件中的作用尚不清楚。现代心电图上通常可用的间隔和向量数据可能提供独立的预后信息,从而改善风险分类。
基于 ECG 指标推导出 CVD 风险方程,并确定其在Framingham 风险评分(FRS)之外的额外获益。
设计、地点和参与者:这项研究包括来自第一届全国健康和营养检查调查(NHANES I)队列(1971-1975 年)的 3640 名随机选择的年龄在 40 至 74 岁之间、无已知 CVD 的社区成年人(1971-1975 年)和来自 NHANES III 队列(1988-1994 年)的 6329 名参与者。参与者来自美国各地。根据从 NHANES I 中生成的计算机生成的 ECG 数据,包括额面 P、R 和 T 轴、心率以及 PR、QRS 和 QT 间隔,推导出评估非致命性和致命性 CVD 事件的风险评分。与年龄和性别一起纳入最具预测性的变量,纳入到 NHANES ECG 风险方程中。在 NHANES III 队列中评估该方程的独立验证。NHANES III 队列的随访于 2006 年 12 月 31 日结束。这项研究的数据分析时间为 2015 年 8 月 11 日至 2016 年 5 月 20 日。
主要终点是 CVD 死亡。次要结局包括 10 年缺血性心脏病和全因死亡。
最终研究样本包括来自两个队列的 9969 名参与者(4714 名男性[47.3%];5255 名女性[52.7%];平均[SD]年龄,55.3[10.1]岁)。NHANES I 队列中,额面 T 轴、心率和心率校正 QT 间期是最重要的 ECG 因素。在验证队列(NHANES III)中,该方程对致命 CVD 的预后提供了信息,风险比(HR)为 3.23(95%CI,2.82-3.72);C 统计量为 0.79(95%CI,0.76-0.81)。当在 Cox 比例风险回归模型中添加到 FRS 时,分类(1%、5%和 10%截断值)净重新分类改善率为 24%。当 FRS 和 ECG 评分结合在一个单一模型中时,C 统计量提高了 0.04(95%CI,0.02-0.06)至 0.80(95%CI,0.77-0.82)。当在合并队列方程中添加 ECG 评分时,也观察到类似的改善。当评估缺血性心脏病和全因死亡的预后信息方程时,结果相似。
基于年龄、性别、心率、额面 T 轴和 QT 间期的 ECG 风险评分可评估 CVD 风险,并且在一个独立的无症状个体队列中,与单独使用 FRS 相比表现良好。虽然心电图风险方程成本低,但需要进一步研究,以确定这种风险分层的额外步骤是否可以改善预防措施并减少 CVD 事件。